Carvedilol Tablet, Film Coated
Product Images NDC 68084-854

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68084-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6.25 mg Carvedilol Tablet Blister

Labels for Carvedilol 6.25 mg film-coated tablets by American Health Packaging. Each label shows the product name, strength, dosage form, NDC 68084-854, barcode, and space for lot number and expiry date. The labeler address in Columbus, Ohio is also present. Multiple identical labels are displayed on the sheet.*

FDA Label Image

6.25 mg Carvedilol Tablets Carton

Carvedilol 6.25 mg film-coated tablets package label from American Health Packaging. The label states 100 tablets (10 strips of 10), with the NDC 68084-854-01. It includes instructions on storage conditions and safety warnings about keeping the drug out of reach of children and not using if blister is damaged.*

FDA Label Image

Zyd00930

Carvedilol 6.25 mg film-coated tablets, round and white. One side is embossed with "Z C L 0" while the other side is plain. Manufactured by American Health Packaging for oral administration.*

FDA Label Image

Structured Formula For Carvedilol (Image 01)

Chemical structure of Carvedilol, showing its molecular framework with specific functional groups including hydroxyl, ether, amine, and methoxyphenyl groups.*

FDA Label Image

Structured Formula For Carvedilol (Image 02)

A line graph comparing percent mortality over time in months between subjects taking Carvedilol and those taking a placebo. The graph shows mortality on the vertical axis and months on the horizontal axis, with separate lines for Carvedilol and Placebo groups, indicating their respective mortality trends.*

FDA Label Image

Structured Formula For Carvedilol (Image 03)

A forest plot displaying hazard ratio comparisons across various patient subgroups, including age, gender, and medical history categories such as prior myocardial infarction, heart failure class (Killip), thrombolytic use, and conditions like diabetes, hypertension, and angina. The plot visualizes treatment effects on these subgroups with confidence intervals around each hazard ratio point.*

FDA Label Image

Figure 1 (Image 04)

A line graph showing percentage mortality over time in months for Carvedilol versus placebo groups. The x-axis represents months from 0 to 21, and the y-axis shows percent mortality from 0 to 30. Two labeled curves illustrate mortality rates, with the Carvedilol group exhibiting a lower mortality rate compared to placebo. A p-value of 0.0014 is indicated.*

FDA Label Image

Figure 2 (Image 05)

A forest plot chart illustrating hazard ratios for different patient subgroups, including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. The x-axis represents the hazard ratio from 0.0 to above 2.0, with confidence intervals shown for each subgroup. A vertical reference line is drawn at a hazard ratio of 1.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.